Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease.
Nelson AJ, Ardissino M, Haynes K, Shambhu S, Eapen ZJ, McGuire DK, Carnicelli A, Lopes RD, Green JB, O'Brien EC, Pagidipati NJ, Granger CB. Nelson AJ, et al. J Am Heart Assoc. 2021 Jan 19;10(2):e016835. doi: 10.1161/JAHA.120.016835. Epub 2021 Jan 12. J Am Heart Assoc. 2021. PMID: 33432843 Free PMC article.
Risk of Total Events With Icosapent Ethyl: Can We Reduce It?
Granger CB, Nelson AJ, Pagidipati NJ. Granger CB, et al. Among authors: nelson aj. J Am Coll Cardiol. 2019 Jun 11;73(22):2803-2805. doi: 10.1016/j.jacc.2019.03.492. J Am Coll Cardiol. 2019. PMID: 31171085 Free article. No abstract available.
Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial).
Nelson AJ, Navar AM, Mulder H, Wojdyla D, Philip S, Granowitz C, Peterson ED, Pagidipati NJ. Nelson AJ, et al. Am J Cardiol. 2020 Oct 1;132:36-43. doi: 10.1016/j.amjcard.2020.07.005. Epub 2020 Jul 12. Am J Cardiol. 2020. PMID: 32773223 Free article. Clinical Trial.
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.
Nelson AJ, Pagidipati NJ, Aroda VR, Cavender MA, Green JB, Lopes RD, Al-Khalidi H, Gaynor T, Kaltenbach LA, Kirk JK, Lingvay I, Magwire ML, O'Brien EC, Pak J, Pop-Busui R, Richardson CR, Reed M, Senyucel C, Webb L, McGuire DK, Granger CB. Nelson AJ, et al. Circulation. 2021 Jul 6;144(1):74-84. doi: 10.1161/CIRCULATIONAHA.121.053766. Epub 2021 Jul 6. Circulation. 2021. PMID: 34228476 Review.
500 results